Daré Bioscience to Launch Flora Sync LF5 Vaginal Probiotic Capsule

Daré Bioscience announced on Thursday that it plans to launch Flora Sync LF5, a new vaginal probiotic capsule, to the consumer market. The company intends to distribute the product as a non-prescription supplement designed to support vaginal health through the introduction of specific bacterial strains.

The company developed Flora Sync LF5 to address imbalances in the vaginal microbiome, utilizing a proprietary formulation of live microorganisms. Daré Bioscience confirmed that the product will be available for purchase through its direct-to-consumer online platform, with retail availability expected to follow in subsequent months. This launch marks the company’s latest expansion into the women’s health consumer products sector, following its previous focus on pharmaceutical development and clinical-stage therapeutic candidates.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 4, 2026

Author

GOAI